Who
Kevin T. Conroy
Director
Company insider
Files Form 4 as: Director, Abbott Laboratories; Director, Align Technology; President and CEO, Exact Sciences; Director, Adaptive Biotechnologies; Director, Epizyme; Director, SomaLogic; Director, Arya Sciences Acquisition; President & CEO, Third Wave Technologies Inc /wi.
In numbers
- Trades disclosed
- 502
- Buys
- 15
- Sells
- 74
- Bought
- $1.4M
- Sold
- $176.8M
- Companies
- 8
- Companies where not an officer
- 6
- First trade
- 1 May 2006
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $31K318 at $98.83 | filing |
| 23 Sep 2026filed 25 Sep 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $5.5M52,507 at $103.99 | filing |
| 23 Sep 2026filed 25 Sep 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $5.5M52,507 at $103.99 | filing |
| 30 Jun 2026filed 1 Jul 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $21K231 at $90.74 | filing |
| 30 Jun 2026filed 1 Jul 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $21K231 at $90.74 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align TechnologyMedical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,836 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,836 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align TechnologyMedical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact SciencesDiagnostics & Labs | SEC FORM 4 Code A | —119,312 at $0.00 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —100,916 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —18,143 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —44,336 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —83,360 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —154,829 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact SciencesDiagnostics & Labs | SEC FORM 4 Code D | —1,397,738 | filing |
The newest 500 lines are listed; the numbers count every line.
News
No headline names them, or the companies they trade most, lately.